Baxter’s Data on Expanded Hemodialysis

Restricted access

Baxter International, in Deerfield, IL, has released data from two independent studies that explored expanded hemodialysis therapy (HDx) with its Theranova™ dialyzer. Expanded hemodialysis refers to applying high retention-onset membranes able to filter out molecules in the mid- to high molecular weight range.

Nephros (South Orange, NJ) gained FDA approval in 2012 for its hemodiafiltration system, the first in the US. Whereas dialysis works on a diffusion principle and filters smaller molecules, hemodiafiltration provides an extra boost of cleansing because it moves molecules through a fluid under pressure and forces out the large waste molecules that might otherwise remain.